CRF Bracket Moves Clinical Trials Forward at 2019 Annual SCOPE Summit

Subject matter experts from CRF Bracket take an active thought-leadership role with key presentations and interactive roundtables at the conference

Plymouth Meeting, PA – February 12, 2019: Running a seamless clinical trial means improving not only data quality but also operational logistics and most importantly the patient experience. Pharmaceutical companies around the world will convene at the 10th annual Summit of Clinical Operations Executives (SCOPE) 2019, where CRF Bracket executives and subject matter experts will discuss technology and best practices to accomplish these essential goals.

Being held from 18-21 February 2019 in Orlando, Florida, the SCOPE Summit is the foremost collaborative gathering of a wide range of clinical operations leaders, and CRF Bracket will take an active role in driving the conversation – and results for patients worldwide – as more sponsors and CROs continue to place an increasing emphasis on modernizing clinical trials.

As SCOPE 2019 examines advances in all aspects of clinical trial planning, management and operations, CRF Bracket will leverage its uniquely integrated global expertise in eCOA, eConsent, IRT, Clinical Trial Supply Management and Patient Engagement at numerous sessions, roundtables, and panels including…

  • Tuesday, Feb 19 at 12:45 pm:  Oliver Cunningham, Director of Client Enablement, will present ‘Achieving Extended Enterprise Supply Chain Maturity Within a Clinical Supply Environment’ as a deep dive into the potential quality improvements and logistical cost efficiencies at an enterprise level.
  • Thursday, Feb 21 at 1:25 pm – Jeff Lee, President, Patient Engagement and eConsent, will deliver ‘The Secret to Unlock Adoption of eClinical Solutions’, to discuss the value and perceived barriers through an interactive discussion on what else is holding back the large-scale adoption of exciting new technologies.

In addition, CRF Bracket will lead and participate in several roundtables and panel discussions focused on important topics such as implementing electronic informed patient consent (eConsent) and supply chain forecasting and management.

CRF Bracket’s CEO, Mike Nolte, together with a cross-team of subject matter experts, will carry the discussion further at their Booth #415 where they will present strategic opportunities to further transform the patient experience and advance clinical research worldwide.

To begin a conversation with CRF Bracket about how technology can help improve your next trial, schedule a meeting or a demo at SCOPE  or visit http://pages.crfhealth.com/2019_SCOPE.html

About CRF Bracket

CRF Bracket was formed in 2018 by the merger of CRF Health and Bracket to provide life science companies with patient-centric technology solutions that advance clinical research and transform the patient experience. The company’s solutions include electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint quality services that combine advanced analytics and therapeutic area-specific scientific consulting. CRF Bracket’s applications are trusted by pharmaceutical companies of all sizes, including all of the top 20 pharmas, as well as CROs, biotechs, and academic institutions on over 4,000 global clinical trials. For nearly 20 years, CRF Bracket has been committed to helping life science companies bring life-changing therapies to patients and communities around the world. To learn more visit www.crfhealth.com and www.bracketglobal.com.

Contact:  media@crfhealth.com, +1 267.498.2350

Connect with CRF Bracket:

CRF Bracket is a Leading Employer in Romania as Demand for eClinical Solutions Grows

Plymouth Meeting, PA – February 6, 2019:  CRF Bracket is celebrating unprecedented success in Romania after opening an eClinical technology facility in the country just two years ago. Celebrating its second anniversary on 6 February since opening its base in lasi, the company’s Romania operation now employs a team of over 200 people in a large office situated in the economic heart of the region and is a leading employer in the area.

CRF Bracket provides life science companies with patient-centric technology for clinical research including electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint quality analytics and services. In 20 years, the company has delivered solutions to over 4,000 global clinical trials

“Romania is a growing market for bio-science, clinical trials and technology, and our success to date confirms CRF Bracket’s commitment to offering global customers a more extensive range of services, as well as regionalized support from dedicated customer teams,” said Adina Talapaga, VP Global Support Services, CRF Bracket in Romania.  “We have a rich talent pool of highly skilled professionals who all contribute immensely to CRF Bracket’s goal of achieving better clinical trials data and helping to simplify the path to approval for life-changing medicines.”

“If you look at the talent and passion of our teams in Romania, perhaps the rapid growth should not be surprising,” said Mike Nolte, CEO of CRF Bracket.  “Still, the scale of success in such a short time frame is unique. It underscores the industry’s accelerating demand for capable, reliable and talented teams to support eClinical solutions wherever clinical trials are administered. We continue to invest aggressively in building great teams at all of our sites, focused on exceptional service and scale worldwide. In 2019 and beyond, we are confident that lasi will continue to grow as another great hub to support customer success.”

The Romanian site is now a fully integrated part of CRF Bracket’s eClinical solutions business and enables the company to offer its global customers a more extensive range of services, as well as regionalized support. With established teams in both R&D and Operations, the Romanian operation will continue to be supported by CRF Bracket’s wider team based at locations across the US, UK and Finland, demonstrating the company’s continuing commitment to providing customers all over the world with its patient-centric solutions.

*****************

About CRF Bracket

CRF Bracket was formed in 2018 by the merger of CRF Health and Bracket to provide life science companies with patient-centric technology solutions that advance clinical research and transform the patient experience. The company’s solutions include electronic clinical outcome assessments (eCOAs), eConsent, patient engagement, interactive response technology (IRT), clinical supply forecasting and management, and endpoint quality services that combine advanced analytics and therapeutic area-specific scientific consulting. CRF Bracket’s applications are trusted by pharmaceutical companies of all sizes, including all of the top 20 pharmas, as well as CROs, biotechs, and academic institutions on over 4,000 global clinical trials. For nearly 20 years, CRF Bracket has been committed to helping life science companies bring life-changing therapies to patients and communities around the world.

To learn more visit http://www.crfhealth.com and www.bracketglobal.com.

Contact:  media@crfhealth.com, +1 267.498.2350

CRF Health and Bracket Announce Merger Closing

Combined company, initially named CRF Bracket, provides Drug Development Companies a Unique Technology and Service Partner for Clinical Research

London, United Kingdom and Wayne, Pennsylvania, USA – September 5, 2018 – CRF Health and Bracket today announced the closing of their merger, bringing together two established clinical research technology leaders. The integrated company, initially named CRF Bracket, provides sponsors and CROs with…

  • Over 20 years of proven patient-centric technology solutions with deep therapeutic area expertise
  • The preeminent eCOA, patient engagement and eConsent solutions
  • Expert rater training, risk based monitoring and data analytics for assessment reliability and consistency
  • Market-leading supply chain solutions to manage research drug delivery from manufacturing to patient

Bracket’s current CEO, Mike Nolte, will assume the role of CEO for the combined company. An experienced leadership team from both organizations will help guide the strategic direction of CRF Bracket, accelerating innovation, scaling a powerful business and staying focused on expert service for customers.

Since 2000, sponsors and CROs of all sizes, including all of the top 20 pharmaceutical companies, have trusted CRF Health and Bracket to support more than 4,000 trials across therapeutic areas.

“These two great teams coming together is a unique moment in this market, and we are moving forward to deliver compelling, dependable patient-centric technology solutions that improve the speed, reliability and insight of clinical research,” said Nolte. “We believe this is an exciting opportunity for our customers and our team, and it creates the foundation of a unified platform with actionable data and insight, highlights a group of unmatched therapeutic area experts, and delivers global scalability. We are just getting started at CRF Bracket, and as we continue to innovate and invest in our combined solutions, we will seek new ways to help our customers bring life-changing therapies to our families and communities around the world.”

David Golde, who leads Genstar’s investment in CRF Bracket, commented, “Genstar is thrilled to be sponsoring the combination of CRF Health and Bracket – two leaders in the clinical research technology industry.  This transformational merger creates an unparalleled set of solutions to help customers conduct clinical trials more efficiently and with a higher probability of success.  This merger also contributes to Genstar’s growing track record of building market-leading companies in the Healthcare industry.”

Philip Russmeyer, Partner at Vitruvian Partners, commented, “We have enjoyed a great partnership with CRF’s world-class management team. CRF Bracket will be a clear global leader in patient-centric clinical research solutions with an outstanding opportunity set, and we congratulate all those involved in a successful combination of the two businesses.”

CRF Bracket was formed by the acquisition of CRF Health from Vitruvian Partners by Genstar Capital (read press release), and by Genstar Capital’s acquisition of Bracket in March 2017 (read press release). To learn more, visit crfhealth.com  or bracketglobal.com.

 

About Bracket

Bracket (bracketglobal.com) is a technology company that accelerates clinical research and improves the experience of patients accessing potentially life-changing therapies. Our solutions, combined with deep scientific and clinical insight, link engaged patients to researchers, provide faster, more reliable decision making, and help provide longer, healthier and more productive lives for our families and communities around the globe. Bracket has over 800 employees and delivers services in more than 90 countries to a diverse base of global customers, including 15 of the top 20 biopharma companies.

 

About CRF Health

CRF Health (crfhealth.com) is the leading global provider of patient-centered eSource technology solutions for the life sciences industry. With experience in more than 800 clinical trials, over 100 languages and across 74 countries, the company delivers best in class, fully integrated eSource solutions for pharma partners. Solutions include TrialMax®, an eCOA suite which consistently demonstrates the industry’s highest data accuracy, patient and site compliance, and patient retention, and TrialConsent®, the patient-centered, intuitive and interactive informed eConsent suite.

About Genstar Capital

Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar manages funds with total capital commitments of approximately $10 billion and targets investments focused on targeted segments of the healthcare, financial services, software, and industrial technology industries.

 

About Vitruvian Partners

Vitruvian is a European growth-focused investment firm specialised in ‘dynamic situations’, where companies undergo growth and change typically driven by technology. Vitruvian helps portfolio companies scale their operations by providing an operational support system and assistance with strategic initiatives including acquisitions. Other notable investments to date include global market leaders in their field such as Just Eat, FarFetch, Skyscanner, EasyPark, Snow Software, Trustpilot, Voxbone, Callcredit, Ebury and others. The €2.4bn Vitruvian Investment Partnership III (“VIP III”) is among the largest pools of capital in Europe supporting innovative and higher growth companies. Vitruvian has backed 30 companies in its first two funds and has assets under management of c. €5 billion, operating out of offices in London, Munich, Stockholm, Luxembourg and San Francisco. More information can be found at: www.vitruvianpartners.com

 

Media Contact:

Kristopher E. Sarajian

Vice President, Global Marketing Operations

CRF Bracket

Kristopher.sarajian@bracketglobal.com

Bracket Patient Engagement and eCOA Innovator Jeff Lee Named to PharmaVOICE 100 Most Inspirational People 2018

Founder of mProve Health passionate about improving the patient experience in clinical trials using modern mobile technologies

King of Prussia, PA – Bracket, a technology company providing solutions for better patient outcomes and actionable insights, is honored to announce patient-centric innovator Jeff Lee has been named one of the PharmaVOICE 100 most inspirational people in the life sciences industry. As President, eCOA, Patient Engagement at Bracket, Lee is dedicated to building solutions that deliver an outstanding user experience, transforming the way patients participate in clinical research.

For more than a dozen years, PharmaVOICE magazine has recognized the most inspirational, motivational, and transformational individuals throughout the life-sciences industry in its annual July/August PharmaVOICE 100 issue. As always, this year’s distinguished honorees were nominated by thousands of PharmaVOICE readers and were selected for inclusion based on how they inspire others, their positive impact on patients and the industry at large, their innovative thinking, their mentorship to the next generation of leaders, and their willingness to give their time and resources to their communities and philanthropic causes.

“I am humbled and honored to be recognized among such a worthy group of inspiring people by PharmaVOICE, especially because nominations come from clinical operations leaders who use and value our solutions,” said Lee. “It’s crucial to be able to put yourself in the mindset of the patient, the research site, the client, employees – or even business partners. This allows for insight and collaboration that many people just don’t unlock. Empathy is a secret weapon for success.”

Lee founded mProve Health in 2010 to improve the patient experience in clinical trials with a BYOD philosophy that makes it easy for patients to stay invested in the study. mProve quickly became a leading provider of patient engagement and eCOA solutions on mobile devices, and was acquired by Bracket in 2017.

“Jeff’s entrepreneurial spirit, visionary approach, and clinical trial expertise all in pursuit of bringing much-needed treatments to patients epitomize what it means to be a PharmaVOICE 100,” says Taren Grom, editor and co-founder, PharmaVOICE. “In addition, he is an inspirational leader who is lifting his teams to new heights in their pursuit to make a difference in the industry.”

Today, 18 of the top 20 pharmaceutical companies currently use Bracket technology solutions to manage their clinical trials. The company’s patient engagement solutions are designed to help study sponsors and CROs improve retention rates in clinical trials, increase compliance to study protocols, and ensure adherence to therapy.

Lee is listed amongst the commanders and chiefs in the PharmaVOICE 100 issue. Read his full profile here.

About Bracket:

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

 

 

 

Discuss and Determine the Future of eClinRO and Computerized Assessments for Alzheimer’s Disease Research with Bracket at AAIC 2018

Schedule a meeting with Bracket’s expert clinicians and data scientists at AAIC exhibit booth #607 to discover the latest technology for capturing and analyzing reliable clinical trial data

King of Prussia, PA – Attendees at the AAIC 2018 meeting, hosted by the Alzheimer’s Association, are invited to join Bracket to discuss and determine the future of eClinRO and computerized assessments in Alzheimer’s Disease research.

Schedule a meeting to begin a conversation with distinguished clinicians and expert data scientists including Amir Kalali, MD, David Miller, MD, Sarah Karas, PsyD, Todd Feaster, PsyD, Todd M. Solomon, PhD, and Pascal Goetghebeur.

Over the years, Bracket has built deep CNS expertise, including the development of specialized solutions for rater training and certification, quality assurance, and computerized assessments built with a focus on optimizing the patient experience. In particular, the Bracket Rater Station™ is a regulatory-compliant technology that has been used to deliver 45,000 unique scale administrations to over 5,000 patients in more than 60 languages. It is an advanced eClinRO tool that improves interview quality while reducing administration and scoring errors.

Get a demo to gain firsthand experience of Bracket technology, including Rater Station, at AAIC.

In addition to subject matter experts and technology solutions, Bracket will continue to contribute to the scientific discussion with papers and poster sessions at the conference:

  • “Analysis of the Rates and Types of Errors on Enhanced eCOA Versions of the Alzheimer’s Diseases Assessment Scale – Cognitive Subscale and Mini Mental State Examination Used in Clinical Trials of Dementia” presented by first author Solomon at location P1-068 on Sunday, July 22
  • “The Use of Statistical Modeling to Complement Data Quality Programs” presented by first author Karas at location P1-064 on Sunday, July 22
  • “Pilot Validation of an Electronic Alzheimer’s Disease Assessment Scale-Cognitive Subscale” presented by first author Solomon at location P2-035 on Monday, July 23
  • “Electronic ADAS-Cog (eADAS-Cog) Data Quality: How Do Countries Compare?” presented by first author Feaster at location P3-018 on Tuesday, July 24
  • White paper describing the importance of computerized cognitive assessments given new FDA guidance for early AD research by first author Goetghebeur available at Bracket exhibit booth #607

To learn more about Bracket and Alzheimer’s Disease research, begin a conversation at AAIC 2018.

About Bracket

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket

Combined organization will bring together complementary strengths with a shared focus on accelerated customer value through patient-centric clinical technology solutions

LONDON and WAYNE, Pa.July 17, 2018  — Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry. As part of the transaction, CRF will be combined with Bracket, a provider of software and technology-enabled solutions utilized in clinical trials. Bracket is a portfolio company of Genstar.

CRF Health has been majority-owned by Vitruvian Partners, a leading growth-and technology-focused investment firm, since 2015.

The newly combined organization will drive accelerated value for pharmaceutical companies and CRO customers, providing patient-centric solutions, combined with deep and broad therapeutic area expertise, across a strong and efficient global footprint.

“CRF Health earned an outstanding reputation with 20 years of experience providing eCOA and now eConsent solutions to the biopharma industry around the world,” said Mike Nolte, who will lead the combined organization as CEO. “CRF’s technology and therapeutic experience dovetail well with our solutions, and they expand our ability to support increasingly complex clinical research. I am excited to bring two outstanding teams together to provide a reliable and scalable platform that accelerates the development of life changing medicines for our families and communities across the globe.”

The combined company will have over 1,500 employees worldwide, and will be in a position to accelerate the penetration of user-friendly technologies across the clinical trial spectrum – driving the transfer from manual, paper based services to electronic while improving service quality and data integrity.

“This is an exciting step forward for patients, clients, and our new combined team,” said Rachel Wyllie, CEO of CRF Health, who will become the Executive Chairman of the combined company. “The complementary nature of the two businesses provides us with the platform and scale for future growth in our dynamic markets, while ensuring our customers have more access to the latest patient-centric innovations in clinical research.”

Jean-Pierre Conte, Chairman and Managing Director at Genstar Capital, added, “Bringing CRF and Bracket together will create a world-class healthcare technology company supporting clinical trials and will accelerate adoption and growth in eCOA, eConsent, patient engagement, rater training and trial supply management solutions. We look forward to working with the outstanding leaders at both organizations. This notable event in pharmaceutical services is another example of Genstar’s private equity strategy of driving change at our portfolio companies to create high-growth and extremely valuable companies. Healthcare is an important sector for Genstar and we continue to identify great opportunities to apply our growth model to build great companies.”

Philip Russmeyer, Partner at Vitruvian Partners, commented, “We are delighted to support the combination of Bracket and CRF to further accelerate, and build upon, the excellent advances that our partnership with the strong management team at CRF has produced over the past years.”

The transaction is expected to be completed by the end of 2018 and is subject to customary closing and regulatory approvals.

Jefferies International Limited served as exclusive financial adviser and Dickson Minto as legal adviser to CRF.  Ropes & Gray LLP served as legal adviser to Genstar Capital.

About Bracket

Bracket (www.bracketglobal.com) is a technology company that accelerates clinical research and improves the experience of patients accessing potentially life-changing therapies. Our solutions, combined with deep scientific and clinical insight, link engaged patients to researchers, provide faster, more reliable decision making, and help provide longer, healthier and more productive lives for our families and communities around the globe. Bracket has over 800 employees and delivers services in more than 90 countries to a diverse base of global customers, including 15 of the top 20 biopharma companies.

About CRF Health

CRF Health is the leading provider of patient-centered eSource technology solutions for the life sciences industry. With experience in more than 800 clinical trials, over 100 languages and across 74 countries, CRF Health’s TrialMax® platform consistently demonstrates the industry’s highest data accuracy, patient and site compliance, and patient retention. The integrated TrialMax platform includes eCOA solutions for collecting PROs (Patient Reported Outcomes), ObsROs (Observer Reported Outcomes), ClinROs (Clinician or Rater Reported Outcomes), and PerfOs (Performance Outcomes), and features TrialConsent®, an electronic solution for collecting and managing informed consent in clinical trials. CRF Health’s eSource solutions improve trial engagement by making the patient the center of the clinical trial process.

About Genstar Capital

Genstar Capital (www.gencap.com) is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar manages funds with total capital commitments of approximately $10 billion and targets investments focussed on targeted segments of the healthcare, financial services, software, and industrial technology industries.

About Vitruvian Partners

Vitruvian is a European growth-focused investment firm specialised in ‘dynamic situations’, where companies undergo growth and change typically driven by technology. Vitruvian helps portfolio companies scale their operations by providing an operational support system and assistance with strategic initiatives including acquisitions. Other notable investments to date include global market leaders in their field such as Just Eat, FarFetch, Skyscanner, EasyPark, Snow Software, Trustpilot, Voxbone, Callcredit, Ebury and others. The €2.4bn Vitruvian Investment Partnership III (“VIP III”) is among the largest pools of capital in Europe supporting innovative and higher growth companies. Vitruvian has backed 30 companies in its first two funds and has assets under management of c. €5 billion, operating out of offices in LondonMunichStockholmLuxembourg and San Francisco. More information can be found at: www.vitruvianpartners.com

 

Bracket to Demonstrate Technology that Brings Pharmaceutical Companies Closer to their Patients at DIA Annual Meeting 2018

Visit booth #2522 to improve the patient experience, enable more reliable data capture in clinical trials, and watch (and play) plenty of soccer

King of Prussia, PA – Bracket, a technology company connecting patients to potentially life-changing therapies through faster and more reliable clinical research, will engage with clinical research leaders to showcase solutions that bring pharmaceutical companies closer to their patients at the DIA Annual Meeting in Boston, MA, from June 24-28, 2018.

Exhibit booth #2522 will be an active center for technology demonstrations and insightful conversations with sponsors and CROs determined to improve the patient experience and capture better, more reliable data worldwide.

Schedule a demo to experience the value of Bracket solutions firsthand.

  • Bracket eCOA: A mobile data collection solution that engages patients, caregivers, and clinical site staff. It can be used on provisioned or personal devices and includes robust services for scale management, data management, logistics, and outcomes advisory.
  • Bracket Patient Engagement: A mobile app and reminder system proven to boost patient compliance and study completion. It has been used by 18 of the top 20 pharmaceutical companies to engage research patients around the globe.
  • Bracket Neuroscience: An advanced solution for collecting clinician-rated endpoint data in neurology studies. Its advanced analytics and scientific services improve study data quality by maximizing rater reliability.
  • Bracket IRT & Clinical Supplies: An industry-trusted, quick-deploy solution for managing randomization and clinical supplies. It integrates seamlessly with Bracket SmartSupplies to forecast, label, distribute, manage and reconcile clinical supplies.

Visitors to the Bracket booth will also have the opportunity to share challenges and brainstorm best practices with subject matter experts including distinguished ePRO Consortium member Serge Bodart, Senior Adviser Outcomes Science, and Jeff Lee, President of eCOA and Patient Engagement, the patient technology innovator who founded mProve Health (acquired by Bracket in 2017).

In addition to technology discussions and live solution demonstrations, Bracket will help provide some well-deserved entertainment breaks with opportunities for casual fun:

  • Live viewings of global soccer tournament matches and a free-to-play foosball table
  • Daily raffles for an Amazon Echo Show
  • The “can’t miss” social event of the conference, Bracket’s annual party with CluePoints, this year to be held on Tuesday, June 26, at The Grand nightclub opening at 10pm. RSVP here then pick up your ticket at the Bracket booth.

“We are moving urgently to deliver new, high-impact capabilities for customers,” said Mike Nolte, Bracket CEO. “Inside Bracket, we’re adding even more expert talent to our team and investing in exciting new patient technology offerings built off years of established success. More importantly, we’re focused on connecting researchers and patients to accelerate the quality and speed of clinical trials through active engagement. Our industry has the noble responsibility to support longer and more productive lives for our families and communities around the world, and we are dedicated to supporting their success with great technology that patients love. I’m excited to share some of it with you at DIA.”

About Bracket

Bracket is a technology company connecting patients to potentially life-changing therapies through faster, more reliable clinical research. We link engaged patients to researchers, deepen insight with clinical expertise, and help provide longer and more productive lives for our families and communities around the world. Featuring innovative solutions for eCOA, Patient Engagement, Neuroscience, and IRT & Clinical Supplies, Bracket helps life science companies and CROs improve the patient experience, capture better data, and create insightful analytics. To learn more about the proven impact patient-centric and science-driven technology can have on your global clinical trials, visit bracketglobal.com.

Bracket Appoints James Jay as Senior Vice President, Endpoint Solutions to Drive Continued Growth of Its Technology and Service Offerings

WAYNE, Pa., — June 5, 2018—Bracket, a leading clinical trial technology and specialty services provider, today announced James Jay has joined the Company as Senior Vice President, Endpoint Solutions, reporting to Bracket’s Chief Executive Officer, Mike Nolte. In this role, James will lead the Bracket business focused on eCOA, Rater Training, Analytics, Cognitive Testing, and Rater Quality technology solutions.

“James brings leadership, vision and creativity to Bracket’s growing team,” said Mike Nolte, CEO. “He will be essential in our ongoing efforts to build patient-centric, innovative technologies, advance our data and analytics strategy and support our pharmaceutical and biotechnology clients.”

James has 18 years of experience building successful software solutions for healthcare and life sciences. For the last six years he led the Global Imaging IT business at Agfa HealthCare, where he transformed the business strategy while creating a new market segment and established early market leadership. Prior to Agfa, James spent 13 years at GE, where he led the Global Cardiology IT business, and held other roles across R&D and program management.

James has an MBA in Global Management from American Intercontinental University and a BS in Computer Science from the University of Oregon.

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Media Contacts

Kristen Everett, Sagefrog, kristene@sagefrog.com

Kris Sarajian, Kristopher.Sarajian@bracketglobal.com

Bracket Appoints Mitch Blumenfeld as Chief Financial Officer

WAYNE, Pa., — May 22, 2018 – Bracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Mitch Blumenfeld as Chief Financial Officer.

Blumenfeld has extensive experience as a financial leader for life science and technology companies. He joins Bracket from PCI Pharma Services, the world’s largest provider of outsourced pharmaceutical packaging and related services where he was responsible for all financial management for 18 facilities across North America, Europe and Australia, led a successful exit to Partners Group and completed five acquisitions in four years.

“The opportunity to help a great business into their next phase of growth is a tremendous opportunity,” said Blumenfeld. “I’m looking forward to the chance to continue my personal investment in the clinical research industry and to support Bracket’s mission to improve the patient experience, while delivering speed and reliability in clinical trials.”

Prior to his time with PCI, Blumenfeld served in business leadership roles at a variety of clinical and technology businesses. From 2006 to 2013 Mitch worked for AmerisourceBergen as the Senior Vice President and CFO of the Drug Corporation and led the integration and finance functions for World Courier, the world leader in global cold chain and clinical trial logistics with offices in over 140 countries.

“Mitch is an outstanding and proven CFO, with a tremendous track record and deep experience transforming and growing great businesses,” said Mike Nolte, CEO at Bracket.  “I’m proud to have him on this team and I look forward to working together to lead Bracket’s future growth.”

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs.

Media Contacts

Kristen Everett, Sagefrog Marketing Group, kristene@sagefrog.com

Adam Butler, Bracket, adam.butler@bracketglobal.com

Bracket Appoints Serge Bodart to Scientific Leadership as eCOA Subject-Matter Expert

May 01, 2018, Wayne, PABracket, a leading clinical trial technology and specialty services provider, today announced the appointment of Serge Bodart, MS, as Senior Advisor, Outcomes Science, where he will build upon the existing breadth and depth of Bracket’s scientific and technical thought leadership while serving specifically as the Company’s electronic clinical outcomes assessments (eCOA) subject-matter expert.

Serge is a seasoned clinical trial technology executive who has been immersed in the eCOA and patient reported outcomes (ePRO) industry for more than 20 years. In addition to serving as a member of the ePRO Consortium for the past four years, Serge also Co-founded and served as Chief Executive Officer to Symfo, a European-based ePRO provider. With international entrepreneurial experience in the space, Serge brings an impressive level of functional and technical knowledge about eCOA to Bracket, understanding its lifecycle from concept to commercialization and its impacts on sites and patients.

“Joining Bracket’s scientific team in a leadership capacity is an exciting opportunity,” said Serge. “I look forward to not only improving how researchers engage with patients in clinical trials on a larger, global scale through Bracket’s advanced and comprehensive eCOA platform, but also helping to legitimize the use of technology in clinical trials as a whole by generating greater awareness with thought leadership.”

In his role as Senior Advisor, Outcomes Science, Serge will provide scientific oversight for all of Bracket’s ePRO activities, and will contribute to our research and new product development initiatives.

“We are pleased to welcome Serge to Bracket and further advance our flagship eCOA and ePRO product suite with his diverse perspectives, unparalleled enthusiasm and subject-matter expertise,” said Jeff Lee, President, mProve Health, a Bracket Company. “His impressive track record of transformational leadership will be a major asset to our rich pipeline of impending and long-term innovations to our eCOA and ePRO platforms, and to advancing the use and adoption of technology in clinical trials a whole.”

Prior to his eCOA career, Serge served as Major and helicopter pilot for more than 20 years in the Belgian Army Aviation. He is currently based in Montreal, Canada and holds a M.S. degree in Telecommunications from the Polytechnic Division of the Royal Military Academy in Brussels, Belgium.

About Bracket

Bracket, with ten offices and more than 800 employees worldwide, is a clinical trial technology and specialty services provider dedicated to helping biopharmaceutical sponsors and contract research organizations increase the power of their clinical research data by leveraging core competencies in Science, Technology, and Service. Bracket eCOA™ is a flexible platform for electronic clinical outcomes assessments. Bracket RTSM™ is a best-in-breed, scalable and configurable clinical IRT solution for the life sciences industry. Bracket SmartSupplies™ is a proven platform for improving a clinical supply chain. Bracket Rater Training and Quality Assurance improve outcomes through customized training and quality assurance programs. Learn more about Bracket at www.bracketglobal.com.

Contact

Kristen Everett
Sagefrog Marketing Group on behalf of Bracket
kristene@sagefrog.com | 267-357-7018